Cimetidine NDC 0378-0372

NDC codes

FDA NDC Directory

Product NDC (as listed)0378-0372Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00378-0372Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0378-0372-01	00378037201	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0372-01)Marketed from May 17, 1994

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cimetidine
Generic name (nonproprietary): cimetidine
Active ingredients: Cimetidine — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Mylan Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074246
Marketing start: May 17, 1994
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 0378-0372_e8d57056-b0e8-4d9b-a239-1c3fe27d875eSPL ID e8d57056-b0e8-4d9b-a239-1c3fe27d875eSPL set ID 06c0a509-026f-44e0-9975-a94a8de51d43RxCUI 197505, 197506, 197507, 197508UNII 80061L1WGDUPC 0303780541016, 0303780317017, 0303780053014, 0303780372016
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400378037201 followed by a unit qualifier and the quantity

Package 00378-0372-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cimetidine tablets are indicated in: 1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks and there is rarely reason to use cimetidine tablets at full dosage for longer than 6 to 8 weeks (see DOSAGE AND ADMINISTRATION: Duodenal Ulcer ). Concomitant antacids should be given as needed for relief of pain. However, simultaneous administration of cimetidine tablets and antacids is not recommended, since antacids have been reported to interfere with the absorption of cimetidine. 2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. Patients have been maintained on continued treatment with cimetidine …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074246

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074246
Product	Strength	Form · route	Labeler	Product NDC
Cimetidine	Cimetidine 800 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-0541
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	Northwind Health Company, LLC	51655-697
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-3574
Cimetidine	Cimetidine 200 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-0053
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	55289-581
Cimetidine	Cimetidine 300 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-0317